Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

被引:54
作者
Raleigh, M. D. [1 ]
Peterson, S. J. [1 ]
Laudenbach, M. [1 ]
Baruffaldi, F. [1 ]
Carroll, F. I. [2 ]
Comer, S. D. [3 ,4 ]
Navarro, H. A. [2 ]
Langston, T. L. [2 ]
Runyon, S. P. [2 ]
Winston, S. [5 ]
Pravetoni, M. [1 ,6 ,7 ]
Pentel, P. R. [1 ,6 ]
机构
[1] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA
[2] Res Triangle Inst, POB 12194, Res Triangle Pk, NC 27709 USA
[3] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, New York, NY USA
[4] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[5] Winston Biopharmaceut Consulting, Boulder, CO USA
[6] Univ Minnesota, Med Sch, Dept Med, Minneapolis, MN USA
[7] Univ Minnesota, Med Sch, Ctr Immunol, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
CONJUGATE VACCINE; RELEASE NALTREXONE; HEROIN-ADDICTS; DRUG-ABUSE; NICOTINE; COCAINE; DEPENDENCE; ANTIBODY; MORPHINE; BRAIN;
D O I
10.1371/journal.pone.0184876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Among vaccines aimed at treating substance use disorders, those targeting opioids present several unique medication development challenges. 1) Opioid overdose is a common complication of abuse, so it is desirable for an opioid vaccine to block the toxic as well as the addictive effects of opioids. 2) It is important that an opioid vaccine not interfere with the action of opioid antagonists used to reverse opioid overdose or treat addiction. 3) Some opioids are immunosuppressive and chronic ongoing opioid use could interfere with vaccine immunogenicity. 4) Although antibody-bound oxycodone is unable to enter the brain because of its size, it might still be able to activate peripheral opioid receptors. To assess vaccine impact on opioid toxicity, rats vaccinated with oxycodone conjugated to keyhole limpet hemocyanin subunit dimer (OXY-dKLH) adsorbed to alum or controls vaccinated with dKLH were compared with regard to oxycodone-induced hotplate analgesia and oxycodone-induced respiratory depression and bradycardia. Vaccination shifted the dose-response curves to the right, representing protection, for each of these endpoints. Naloxone was equally effective in both OXY-dKLH and control groups, providing complete and rapid reversal of respiratory depression. The administration of a long-acting naltrexone formulation during vaccination did not impair vaccine immunogenicity in mice. Similarly, serum anti-oxycodone antibody titers were not altered by continuous morphine infusion during vaccination compared to opioid-naive controls. Competitive ELISA assay showed negligible or low affinity of immune antiserum for endogenous opioids or opioid antagonists. In vitro receptor binding assays showed that antibody-bound oxycodone does not activate mu opioid receptors. These data support further study of OXY-dKLH as a potential treatment for oxycodone abuse and suggest that vaccination might also reduce the severity of oxycodone overdose.
引用
收藏
页数:18
相关论文
共 52 条
[1]  
Akbarzadeh A., 2009, Journal of Pharmacology and Toxicology, V4, P30, DOI 10.3923/jpt.2009.30.35
[2]  
Akbarzadeh A, 2007, ASAIN J BIOCH, V2, P58
[3]   Opiate analgesics contribute to the development of post-injury immunosuppression [J].
Alexander, M ;
Daniel, T ;
Chaudry, IH ;
Schwacha, MG .
JOURNAL OF SURGICAL RESEARCH, 2005, 129 (01) :161-168
[4]   Barriers to Enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders [J].
Appel, PW ;
Ellison, AA ;
Jansky, HK ;
Oldak, R .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2004, 30 (01) :129-153
[5]   Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination [J].
Borg, L ;
Khuri, E ;
Wells, A ;
Melia, D ;
Bergasa, NV ;
Ho, A ;
Kreek, MJ .
ADDICTION, 1999, 94 (04) :489-493
[6]   Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs [J].
Bremer, Paul T. ;
Kimishima, Atsushi ;
Schlosburg, Joel E. ;
Zhou, Bin ;
Collins, Karen C. ;
Janda, Kim D. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (11) :3772-3775
[7]   Drugs of Abuse, Immune Modulation, and AIDS [J].
Cabral, Guy A. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (03) :280-295
[8]   Sustained-release naltrexone: novel treatment for opioid dependence [J].
Comer, Sandra D. ;
Sullivan, Maria A. ;
Hulse, Gary K. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (08) :1285-1294
[9]   Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers [J].
Cooper, Ziva D. ;
Sullivan, Maria A. ;
Vosburg, Suzanne K. ;
Manubay, Jeanne M. ;
Haney, Margaret ;
Foltin, Richard W. ;
Evans, Suzette M. ;
Kowalczyk, William J. ;
Saccone, Phillip A. ;
Comer, Sandra D. .
BEHAVIOURAL PHARMACOLOGY, 2012, 23 (03) :271-279
[10]  
Fahim REF, 2013, EXPERT REV VACCINES, V12, P333, DOI [10.1586/erv.13.13, 10.1586/ERV.13.13]